| 摘要 |
Cosmetic topical skin treatment composition comprises 2-benzyl-indan-1-one compounds (I), at least one antioxidant comprising 6,7-disubstituted-2,2-dialkyl-chroman compounds (II) or -chromene compounds (III), preferably lipochroman-6, ubiquinones, preferably coenzyme Q10, quercetin, ellagic acid and/or ellagate, hydroxystilbene oligomers, their alkyl ethers and/or their esters, xanthophylls, preferably astaxanthin, and/or superoxide dismutases, in a carrier. Cosmetic topical skin treatment composition comprises 2-benzyl-indan-1-one compounds of formula (I) and at least one antioxidant comprising 6,7-disubstituted-2,2-dialkyl-chroman compounds of formula (II) or -chromene compounds of formula (III) preferably lipochroman-6, ubiquinones, preferably coenzyme Q10, quercetin, ellagic acid and/or ellagate, hydroxystilbene oligomers, their alkyl ethers and/or their esters, xanthophylls, preferably astaxanthin, and/or superoxide dismutases, in a carrier. R1, R2 : H, CH 3, CH 2CH 3, CH(CH 3) 2or -(CH 2) nCH 3; R3, R4 : H, CH 3, CH 2CH 3, CH(CH 3) 2, (CH 2) kCH 3, OH, OCH 3, OCH 2CH 3, OCH(CH 3) 2or -O(CH 2) mCH 3; dotted line : a double bond or two hydrogen atoms; R111, R112 : OH, OCH 3or CF 3CH 2O; R113, R114 : 1-4C-alkyl; and m, n, k : 2-11. [Image] ACTIVITY : Dermatological. MECHANISM OF ACTION : None given. |
